|
|
||||||||
Department of Immunology and Animal Sciences, Puleva Biotech SA, Granada, Spain
Corresponding author: Federico Lara-Villoslada; E-mail: flara{at}pulevabiotech.es.
| ABSTRACT |
|---|
|
|
|---|
These results suggest that the balance between caseins and whey proteins plays an important role in the sensitization capacity of cows milk, and its modification might be a way to reduce the allergenicity of cows milk.
Key Words: casein whey protein cows milk food allergy
Abbreviation key: CM = cows milk, CMP = cows milk protein, CMPA = cows milk protein allergy, CT = cholera toxin, MCM = modified cows milk
| INTRODUCTION |
|---|
|
|
|---|
The best infant nutrition is breast milk, because in addition to having many factors (e.g., IgG, lysozyme, lactoferrin, lactoperoxidase, growth factors) that protect the newborn from the passage of antigens through the gut barrier, its protein is not allergenic to the offspring (Lovegrove et al., 1994; Lonnerdal, 2003). In contrast, cows milk proteins (CMP) are recognized by the immune system of some newborn infants as foreign proteins, thus causing allergic reactions. The role of different CMP in the origin of CMPA has been studied. Although it is not clear which are the major allergens in cows milk, several studies demonstrate that most children with CMPA synthesize antibodies principally against
-casein and ß-LG (Restani et al., 1999; Bevilacqua et al., 2001; Ametani et al., 2003). Results obtained in our laboratory demonstrated that goats milk is less allergenic than cows milk in a murine model of milk atopy (Lara-Villoslada et al., 2004) and we hypothesized that this could be due to the lower amount of
-casein in goat milk.
The casein:whey protein ratio in native cows milk is 80:20. Because a reduction of
-casein might result in a reduction of allergenicity, it would be interesting to analyze the allergenicity of modified milk with a different balance between casein and whey proteins.
To clarify whether milk with a modified casein:whey protein ratio is less allergenic than native cows milk, we used a murine model of milk sensitization previously published (Li et al., 1999). This is a model of milk atopy that exhibits the characteristics of type I hypersensitivity reactions. Three-week-old (just after weaning) Balb/c mice were orally sensitized by administering cows milk or modified cows milk plus cholera toxin (CT). Plasma levels of specific IgG1 and histamine concentration were determined, and the role of T cells involved in the regulation of cows milk hypersensitivity was investigated by evaluation of the proliferation ratio in spleen cells.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Homogenized cows milk (CM) was obtained from Puleva Food S.A. (Granada, Spain). A modified cows milk (MCM) with a casein:whey protein ratio of 40:60 was prepared. Fifty milliliters of CM was mixed with 50 mL of a lactose solution (50 mg/mL) to maintain the same lactose concentration as in the original milk. Finally, 1.78g of a whey protein concentrate was added to the mixture to modify the milk to a final casein:whey ratio of 40:60.
The protein content in CM and MCM was measured by the Kjeldahl method as previously described (AOAC, 1980). To analyze protein composition of CM and MCM, SDS-PAGE was carried out on a 25-µg sample of protein from each milk. Both milks were stored at 20°C in 1-mL aliquots and thawed immediately before sensitization of mice.
Animals
Female Balb/c mice (3 wk old, immediately after weaning) were purchased from the Granada University breeding colony (Granada, Spain), and housed under a temperature (22°C) and light-controlled (12 h) cycle. Animals (n = 8 per group) were maintained on a regular mouse chow diet under specific-pathogen-free conditions. Guidelines for the care and use of animals were followed as described (Institute of Laboratory Animal Resource Commission of Life Sciences, 1996). The global experiment was conducted 3 times with similar results.
Sensitization and Challenge by Oral Administration of Antigen
Mice were sensitized intragastrically with CM or MCM, plus CT as an adjuvant, and boosted 5 times at weekly intervals. Oral gavage was performed using a polyvinyl chloride tube-feeding needle purchased from Vygon (Ecoue, France). Mice received 1 mg of CMP (CM group) or MCM protein (MCM group) per gram of BW together with 0.3 µg/g of CT. To avoid the effect of the adjuvant per se, a group of mice received CT in PBS (control group). Six weeks after the first oral gavage, mice were fasted overnight and challenged intragastrically with 2 doses of CMP (30 mg/mouse) given 30 min apart. Thirty minutes after the last challenge, mice were killed by intraperitoneal administration of sodium pentothal (50 mg/kg), and blood was collected by cardiac puncture in tubes containing EDTA. Spleen and intestine were removed from each mouse and weighed.
Evaluation of Symptoms
Gastrointestinal symptoms were evaluated as diarrhea and appeared within 7 d after the second dose. Animals that suffered from diarrhea on (at least) 2 consecutive occasions were considered positive cases.
Immediately after challenge, hypersensitivity responses were evaluated using a scoring system modified slightly from previous reports (Li et al., 1999), and scored as follows: 0 = no symptoms; 1 = scratching and rubbing around the nose and head; 2 = puffiness around the eyes and mouth and pilar erecti; 3 = decreased activity with increased respiratory rate; 4 = wheezing and labored respiration; 5 = cyanosis around the mouth and the tail; and 6 = death. The evaluation of symptoms was performed by 2 independent investigators who were blinded to the study treatments.
Determination of Plasma Histamine Levels
Plasma histamine levels were determined using an enzyme immunoassay kit (IBL Laboratories, Hamburg, Germany) following the manufacturer recommendations (Lara-Villoslada et al., 2004).
Measurement of ß-LG-Specific IgG1 in Plasma
Blood was centrifuged (3500 x g for 10 min at 4°C, and plasma aliquots were collected and frozen at 80°C. Levels of specific IgG1 to ß-LG were measured as previously described (Li et al., 1999). Briefly, 96-well plates were coated with 20 µg/mL of ß-LG in coating buffer (0.5 M Na2CO3). After overnight incubation at 4°C, plates were washed 3 times with wash solution (50 mM Tris, 0.14 M NaCl, 0.05% Tween 20) and blocked with blocking solution (50 mM Tris, 0.14 M NaCl, 1% BSA). Then, plasma samples were added to the plates and incubated for 1 h at room temperature (25°C). Plates were washed 3 times, and 100 µL of goat antimouse IgG1 antibody conjugated with peroxidase (Bethyl Laboratories) was added for 1 h at 25°C. Staining was performed with 3,3'-5,5'-tetramethyl-benzidine (TMB) (Sigma Chemical Co.) for 30 min at 25°C in the dark, stopped with 0.1 N HsSO4, and plates were read at 450 nm. Results were expressed as optical density ± SD. All analyses were performed in duplicate.
Culture of Spleen Cells
Spleens were removed from all mice 30 min after the last challenge and homogenized in complete culture medium (Dulbeccos Modified Eagles medium plus 10% fetal bovine serum with 1% penicillin/streptomycin). After centrifugation (1500 x g, 5 min) erythrocytes were lysed with lysing solution (1.7 M NH4Cl, 0.12 M KHCO3, 0.009 M EDTA) for 15 min at 4°C. Resting cells were counted using a hemacytometer and cultured to perform proliferation and stimulation assays in complete culture medium (Dulbeccos Modified Eagles medium + 10% fetal bovine serum). Cells were incubated at 37°C in a humidified 5% CO2 atmosphere.
Proliferation Assay
Spleen-derived lymphocytes were cultured in 24-well plates (2 x 106 cells/well) in 1 mL of medium per well. Lymphocytes from each mouse were divided into 2 wells, one incubated in the absence of proteins (basal), and the other in the presence of CMP (100 µg/mL). [3H]-Thymidine (1 µCi/mL) (Amersham Biosciences, Arlington Heights, IL) was added to each well and incubated at 37°C in a humidified 5% CO2 atmosphere. After 48 h, plates were centrifuged (1500 x g for 5 min) and supernatants were discarded. To fix cells, 500 µL of ice-cold 70% methanol was added to each well. After 3 washes in ice-cold 10% TCA, cells were solubilized in 1% SDS and 0.3 N NaOH at 25°C. Radioactivity was counted by liquid scintillation using a 2100 TriCarb Packard (Meridien, CT) scintillation counter. Each sample analysis was performed in duplicate and the results were expressed as the mean ± SD.
Statistical Analysis
Statistical significance (P < 0.05) was calculated by Students t-test in case of parametric parameters such as the results of ELISA and proliferation assays. All tests were performed with one tail following the 2-sample equal variance model (homoscedastic). For nonparametric parameters (score, intestine weight/BW ratio, and number of mice with diarrhea), Mann-Whitney or Fisher tests were used to determine statistical significance (P < 0.05). Finally, the Spearman test was used for the statistical analysis of the correlation between serum histamine concentration and hypersensitivity score.
| RESULTS |
|---|
|
|
|---|
|
|
|
Because lymphocytes play a key role in the development of CMPA, the spleen from each mouse was removed and weighed. Spleen-derived lymphocytes were counted and cultured to perform proliferation assays and to study their response to different stimuli. Lymphocytes from CM-sensitized mice significantly increased their proliferation ratio when CMP was added to the culture medium (Figure 3
). In contrast, CMP failed to induce a significant increase in the proliferation ratio of lymphocytes from the MCM group. However, this increase in the proliferation ratio in the CM group was not reflected in spleen weight and number of cells, which were similar in all groups (data not shown), suggesting that the number of lymphocytes sensitized to CMP represents a low percentage of total spleen cells.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
To bypass the tendency of mice to develop oral tolerance, we used CT, which has been reported to stimulate a T helper 2 (Th2) response and the production of IgG1 antibodies (Snider et al., 1994; Marinaro et al., 1995). Furthermore, Balb/c mice were used because this strain of mice is prone to develop Th2 responses more readily than other strains (Sun et al., 2001).
Our results suggest that cows milk with a casein:whey protein ratio of 40:60 is less allergenic than native cows milk. In fact, plasma levels of IgG1 to ß-LG and histamine release were lower in the MCM group, in spite of a higher concentration of this protein in MCM, suggesting a less important sensitization in mice from this group. Similar results were obtained with levels of IgG1 to casein (data not shown).
These results were consistent with lymphocyte proliferation in the presence of CMP, because lymphocytes from the MCM group showed a weaker response than those from CM group. Taken together, these results might indicate lesser sensitization capacity of cows milk with lower casein content.
It is well known that the allergenicity of formulas for infant nutrition is based on protein composition. At present, the most common alternative to conventional cows milk formula in children with CMPA is extensively hydrolyzed formula, which is based on cows milk submitted to heat and enzymatic treatment to hydrolyze milk proteins, converting those proteins into low molecular weight peptides (up to 3000 Da), which do not normally act as allergens. However, several studies demonstrated that such formulas failed to induce the desired level of oral tolerance in rodents (Fritsché et al., 1997; Fritsché, 1998). Partially hydrolyzed formulas are also available, in which the nitrogen source consists of peptides with a molecular weight between 2000 and 10,000 Da. Those formulas have been demonstrated to be better at inducing oral tolerance (Fritsché et al., 1997), but some studies in newborn infants with a high risk of allergies report a higher incidence of clinical manifestations up to 18 mo of age after feeding partially hydrolyzed formulas (Halken et al., 2000). On this basis, our aim was to demonstrate that the modified cows milk described in this work was less allergenic than native cows milk, to prevent the initiation of the allergic reaction to CMP.
To our knowledge, this is the first study comparing the allergenicity of 2 cows milks with differing protein compositions. Surprisingly, cows milk with a casein:whey protein ratio of 40:60 is normally used in infant formulas, probably to mimic human breast milk; thus, its allergenicity is also reduced, albeit unintentionally.
Previous studies in our laboratory demonstrated that goats milk is less allergenic than cows milk (Lara-Villoslada et al., 2004). We hypothesized that this decrease in allergenicity could be due to the lower content in
-casein of goat milk, because it has been previously demonstrated that goats milk with defective
-casein decreases sensitization to ß-LG (Bevilacqua et al., 2001).
The mechanisms by which cows milk with a lower casein content can be less allergenic than native cows milk is unknown, but could be related to biochemical interactions between casein and ß-LG. The digestion of ß-LG, a protein known to be resistant to gastric pepsin hydrolysis, might be facilitated by lower casein content, as it is known that caseins and ß-LG are tightly linked into the casein micelles.
It may be that, from an immunological point of view,
-casein initiated sensitization due to its potential higher allergenicity, and thus triggered a Th2 response, causing a misbalance between Th1/Th2 immune equilibrium, and so a child would be prone to secondary sensitization by other cows milk proteins, such as ß-LG. In this sense, the absence or reduction of
-casein content might inhibit the initiation of the allergenic course to milk proteins.
Our results are consistent with both hypotheses, because animals from the MCM group have lower levels of ß-LG to IgG1, in spite of the higher concentration of this protein in MCM. This finding is probably due to the lower casein content in MCM.
Finally, another possibility to explain this fact could be related to the intestinal microflora. There is evidence to believe that the fecal flora composition of infants depends on protein quality of infant formulas. Balmer et al. (1989) compared the effect of casein with whey formula and reported significant differences in the fecal flora composition of infants. The number of bifidobacteria and lactobacilli in the whey group exceeded that in the casein group. As it is known that probiotics can reduce the prevalence of atopic disease (Kalliomäki et al., 2001), a formula increasing the number of these beneficial intestinal bacteria could be involved in reducing food allergenicity.
It is important to note that a cows milk formula with a modified casein/whey protein ratio could be preventive by reducing the incidence of CMPA when given to nonsensitized children. However, children with established CMPA would undoubtedly react against such a formula.
In conclusion, our results might help to elucidate the influence of protein quality in the development of milk sensitization. Further studies are needed to confirm the role of casein and whey proteins in milk allergenicity, as well as the mechanisms to bypass the tendency of the immune system to react against cows milk proteins.
Received for publication September 7, 2004. Accepted for publication January 19, 2005.
| REFERENCES |
|---|
|
|
|---|
s1-casein genotype decreases intestinal and systemic sensitization to ß-lactoglobulin in guinea pigs. J. Dairy Res. 68:217227.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |